|Bid||180.00 x 1300|
|Ask||285.00 x 800|
|Day's range||222.93 - 231.60|
|52-week range||218.28 - 324.81|
|Beta (5Y monthly)||0.66|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
It hasn't been the best quarter for Insulet Corporation ( NASDAQ:PODD ) shareholders, since the share price has fallen...
Investors are optimistic about Insulet's (PODD) better-than-expected revenues and solid revenue growth across the Omnipod product line.
Insulet (PODD) reports better-than-expected revenues for third-quarter 2021 on strong performance of Omnipod, both in U.S. and international markets.